Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP
Abstract Immune thrombocytopenia (ITP) is an autoimmune condition associated with multiple risk factors including viral infections (hepatitis B virus/hepatitis C virus/cytomegalovirus, HIV, and recently severe acute respiratory syndrome coronavirus 2) and vaccines. Though immune mechanisms have been...
Gespeichert in:
Veröffentlicht in: | Open Forum Infectious Diseases 2021-07, Vol.8 (7) |
---|---|
Hauptverfasser: | , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | |
---|---|
container_issue | 7 |
container_start_page | |
container_title | Open Forum Infectious Diseases |
container_volume | 8 |
creator | Jawed, Muzamil Khalid, Amna Rubin, Mayer Shafiq, Ramsha Cemalovic, Nail |
description | Abstract
Immune thrombocytopenia (ITP) is an autoimmune condition associated with multiple risk factors including viral infections (hepatitis B virus/hepatitis C virus/cytomegalovirus, HIV, and recently severe acute respiratory syndrome coronavirus 2) and vaccines. Though immune mechanisms have been proposed to explain the pathogenesis of acute ITP, autoimmunity with the coronavirus disease 2019 (COVID-19) vaccine is still unclear and needs further research. We report a case of acute ITP after administration of the Pfizer-BioNTech mRNA COVID-19 vaccine in a patient with previously stable ITP. |
doi_str_mv | 10.1093/ofid/ofab343 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8294682</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A776255883</galeid><oup_id>10.1093/ofid/ofab343</oup_id><sourcerecordid>A776255883</sourcerecordid><originalsourceid>FETCH-LOGICAL-c427t-978269c6d642ab60b478060256c7836f7fdd106146c0f9ec99d19e3fa7a881973</originalsourceid><addsrcrecordid>eNp9kUtLAzEUhYMoKtqdPyA7FRzNYyaPjVDqqyC0YNVlyGSSNjKTlHko_fdGKqIbuZB7Sb5zbuAAcILRJUaSXkXnq3TokuZ0BxwSSkQmZMF3f80HYNR1bwghjFGBuNwHB4lGnNP8ELyNzdBbOG2aIVi4WLWxKaPZ9HFtg9fwbLqYn8O7WNfxw4clnMxepjcZlvBFG-OD7n0M0Aeo4TzNNvTw1fcrOG_tu49DV2_gU6_LOi1YzI_BntN1Z0ff_Qg8390uJg_Z4-x-Ohk_ZiYnvM8kF4RJwyqWE10yVOZcIIZIwQwXlDnuqgojhnNmkJPWSFlhaanTXAuBJadH4Hrrux7KxlYm_arVtVq3vtHtRkXt1d-X4FdqGd-VIDJngiSDy63BUtdW-eBiwkyqyjbexGCdT_djzhkpCiFoElxsBaaNXdda97MMI_WVk_rKSX3nlPDTLR6H9f_kJ1S7ksM</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP</title><source>Oxford Journals Open Access Collection</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>PubMed Central</source><creator>Jawed, Muzamil ; Khalid, Amna ; Rubin, Mayer ; Shafiq, Ramsha ; Cemalovic, Nail</creator><creatorcontrib>Jawed, Muzamil ; Khalid, Amna ; Rubin, Mayer ; Shafiq, Ramsha ; Cemalovic, Nail</creatorcontrib><description>Abstract
Immune thrombocytopenia (ITP) is an autoimmune condition associated with multiple risk factors including viral infections (hepatitis B virus/hepatitis C virus/cytomegalovirus, HIV, and recently severe acute respiratory syndrome coronavirus 2) and vaccines. Though immune mechanisms have been proposed to explain the pathogenesis of acute ITP, autoimmunity with the coronavirus disease 2019 (COVID-19) vaccine is still unclear and needs further research. We report a case of acute ITP after administration of the Pfizer-BioNTech mRNA COVID-19 vaccine in a patient with previously stable ITP.</description><identifier>ISSN: 2328-8957</identifier><identifier>EISSN: 2328-8957</identifier><identifier>DOI: 10.1093/ofid/ofab343</identifier><identifier>PMID: 34307734</identifier><language>eng</language><publisher>US: Oxford University Press</publisher><subject>Autoimmunity ; Complications and side effects ; Coronaviruses ; Novel ID Cases ; Pharmaceutical industry ; Risk factors ; RNA ; Severe acute respiratory syndrome ; Thrombocytopenia ; Vaccination ; Virus diseases</subject><ispartof>Open Forum Infectious Diseases, 2021-07, Vol.8 (7)</ispartof><rights>The Author(s) 2021. Published by Oxford University Press on behalf of Infectious Diseases Society of America. 2021</rights><rights>COPYRIGHT 2021 Oxford University Press</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c427t-978269c6d642ab60b478060256c7836f7fdd106146c0f9ec99d19e3fa7a881973</citedby><cites>FETCH-LOGICAL-c427t-978269c6d642ab60b478060256c7836f7fdd106146c0f9ec99d19e3fa7a881973</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294682/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294682/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,723,776,780,860,881,1598,27901,27902,53766,53768</link.rule.ids></links><search><creatorcontrib>Jawed, Muzamil</creatorcontrib><creatorcontrib>Khalid, Amna</creatorcontrib><creatorcontrib>Rubin, Mayer</creatorcontrib><creatorcontrib>Shafiq, Ramsha</creatorcontrib><creatorcontrib>Cemalovic, Nail</creatorcontrib><title>Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP</title><title>Open Forum Infectious Diseases</title><description>Abstract
Immune thrombocytopenia (ITP) is an autoimmune condition associated with multiple risk factors including viral infections (hepatitis B virus/hepatitis C virus/cytomegalovirus, HIV, and recently severe acute respiratory syndrome coronavirus 2) and vaccines. Though immune mechanisms have been proposed to explain the pathogenesis of acute ITP, autoimmunity with the coronavirus disease 2019 (COVID-19) vaccine is still unclear and needs further research. We report a case of acute ITP after administration of the Pfizer-BioNTech mRNA COVID-19 vaccine in a patient with previously stable ITP.</description><subject>Autoimmunity</subject><subject>Complications and side effects</subject><subject>Coronaviruses</subject><subject>Novel ID Cases</subject><subject>Pharmaceutical industry</subject><subject>Risk factors</subject><subject>RNA</subject><subject>Severe acute respiratory syndrome</subject><subject>Thrombocytopenia</subject><subject>Vaccination</subject><subject>Virus diseases</subject><issn>2328-8957</issn><issn>2328-8957</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>TOX</sourceid><recordid>eNp9kUtLAzEUhYMoKtqdPyA7FRzNYyaPjVDqqyC0YNVlyGSSNjKTlHko_fdGKqIbuZB7Sb5zbuAAcILRJUaSXkXnq3TokuZ0BxwSSkQmZMF3f80HYNR1bwghjFGBuNwHB4lGnNP8ELyNzdBbOG2aIVi4WLWxKaPZ9HFtg9fwbLqYn8O7WNfxw4clnMxepjcZlvBFG-OD7n0M0Aeo4TzNNvTw1fcrOG_tu49DV2_gU6_LOi1YzI_BntN1Z0ff_Qg8390uJg_Z4-x-Ohk_ZiYnvM8kF4RJwyqWE10yVOZcIIZIwQwXlDnuqgojhnNmkJPWSFlhaanTXAuBJadH4Hrrux7KxlYm_arVtVq3vtHtRkXt1d-X4FdqGd-VIDJngiSDy63BUtdW-eBiwkyqyjbexGCdT_djzhkpCiFoElxsBaaNXdda97MMI_WVk_rKSX3nlPDTLR6H9f_kJ1S7ksM</recordid><startdate>20210701</startdate><enddate>20210701</enddate><creator>Jawed, Muzamil</creator><creator>Khalid, Amna</creator><creator>Rubin, Mayer</creator><creator>Shafiq, Ramsha</creator><creator>Cemalovic, Nail</creator><general>Oxford University Press</general><scope>TOX</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>IAO</scope><scope>5PM</scope></search><sort><creationdate>20210701</creationdate><title>Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP</title><author>Jawed, Muzamil ; Khalid, Amna ; Rubin, Mayer ; Shafiq, Ramsha ; Cemalovic, Nail</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c427t-978269c6d642ab60b478060256c7836f7fdd106146c0f9ec99d19e3fa7a881973</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Autoimmunity</topic><topic>Complications and side effects</topic><topic>Coronaviruses</topic><topic>Novel ID Cases</topic><topic>Pharmaceutical industry</topic><topic>Risk factors</topic><topic>RNA</topic><topic>Severe acute respiratory syndrome</topic><topic>Thrombocytopenia</topic><topic>Vaccination</topic><topic>Virus diseases</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Jawed, Muzamil</creatorcontrib><creatorcontrib>Khalid, Amna</creatorcontrib><creatorcontrib>Rubin, Mayer</creatorcontrib><creatorcontrib>Shafiq, Ramsha</creatorcontrib><creatorcontrib>Cemalovic, Nail</creatorcontrib><collection>Oxford Journals Open Access Collection</collection><collection>CrossRef</collection><collection>Gale Academic OneFile</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Open Forum Infectious Diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Jawed, Muzamil</au><au>Khalid, Amna</au><au>Rubin, Mayer</au><au>Shafiq, Ramsha</au><au>Cemalovic, Nail</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP</atitle><jtitle>Open Forum Infectious Diseases</jtitle><date>2021-07-01</date><risdate>2021</risdate><volume>8</volume><issue>7</issue><issn>2328-8957</issn><eissn>2328-8957</eissn><abstract>Abstract
Immune thrombocytopenia (ITP) is an autoimmune condition associated with multiple risk factors including viral infections (hepatitis B virus/hepatitis C virus/cytomegalovirus, HIV, and recently severe acute respiratory syndrome coronavirus 2) and vaccines. Though immune mechanisms have been proposed to explain the pathogenesis of acute ITP, autoimmunity with the coronavirus disease 2019 (COVID-19) vaccine is still unclear and needs further research. We report a case of acute ITP after administration of the Pfizer-BioNTech mRNA COVID-19 vaccine in a patient with previously stable ITP.</abstract><cop>US</cop><pub>Oxford University Press</pub><pmid>34307734</pmid><doi>10.1093/ofid/ofab343</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 2328-8957 |
ispartof | Open Forum Infectious Diseases, 2021-07, Vol.8 (7) |
issn | 2328-8957 2328-8957 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8294682 |
source | Oxford Journals Open Access Collection; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; PubMed Central |
subjects | Autoimmunity Complications and side effects Coronaviruses Novel ID Cases Pharmaceutical industry Risk factors RNA Severe acute respiratory syndrome Thrombocytopenia Vaccination Virus diseases |
title | Acute Immune Thrombocytopenia (ITP) Following COVID-19 Vaccination in a Patient With Previously Stable ITP |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-13T13%3A03%3A43IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Acute%20Immune%20Thrombocytopenia%20(ITP)%20Following%20COVID-19%20Vaccination%20in%20a%20Patient%20With%20Previously%20Stable%20ITP&rft.jtitle=Open%20Forum%20Infectious%20Diseases&rft.au=Jawed,%20Muzamil&rft.date=2021-07-01&rft.volume=8&rft.issue=7&rft.issn=2328-8957&rft.eissn=2328-8957&rft_id=info:doi/10.1093/ofid/ofab343&rft_dat=%3Cgale_pubme%3EA776255883%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/34307734&rft_galeid=A776255883&rft_oup_id=10.1093/ofid/ofab343&rfr_iscdi=true |